# Thymia

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/thymia

- Industry: Healthcare
- Headquarters: London, UK
- Website: www.thymia.ai
- Total disclosed funding: $2.8M
- Latest round: Seed (May 17, 2023)
- Investors on record: 5

## About

Founded in 2020 and based in London, UK, Thymia Limited develops and operates an AI-integrated online platform that analyzes mental health and illnesses using visible physical conditions. The company was founded by the CEO Dr. Emilia Molimpakis, alongside Dr. Stefano Goria. In June 2021, the company received its latest funding from a group of investors that includes Form Ventures, Kodori AG, and Calm/Storm

The company's product is an AI-integrated online platform that analyzes the mental health status and illnesses of a certain patient using visible physical conditions such as facial microexpressions & speech. The platform gathers helpful data via a set of activities and video games to assess the severity of the mental health of the patient. During sessions, patients can log in to the platform for continuous remote monitoring to identify if the patient's treatment is working. 

The company's revenue is generated by the appointments and logs of various patients to its platform who undergoes mental health issues.

The company plans to gather additional data needed to expand the Thymia product and grow its technical and commercial teams.

## Funding rounds

- Seed, May 17, 2023, $2.8M — SyndicateRoom, Entrepreneur First, Form Ventures, Calm/Storm Ventures, Kodori

## Investors

- SyndicateRoom (https://capitalatlas.ai/funds/syndicateroom) — Seed
- Entrepreneur First (https://capitalatlas.ai/funds/entrepreneur-first) — Seed
- Form Ventures (https://capitalatlas.ai/funds/form-ventures) — Seed
- Calm/Storm Ventures (https://capitalatlas.ai/funds/calm-storm-ventures) — Seed
- Kodori (https://capitalatlas.ai/funds/kodori) — Seed